Rapid evolution of chronic viral hepatitis into hepatocellular carcinoma after beta-interferon treatment

Panminerva Medica

Volumn 41, Issue 1, 1999, Pages 59-61

  Malaguarnera, M ^a   Restuccia, S ^b   Di Fazio, I ^b   Di Marco, R ^b   Pistone, G ^b   Trovato, B A ^b  

^a CANNIZZARO HOSPITAL   (Italy)

^b NONE

Author keywords

Carcinoma, hepatocellular; Cytokines; Hepatitis B; Hepatitis C; Interferons

Indexed keywords

ANTIVIRUS AGENT; BETA INTERFERON;

ARTICLE; CASE REPORT; DISEASE COURSE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; TIME; VIROLOGY;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-BETA; LIVER NEOPLASMS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0033087188     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Tanaka Y, Esumi M, Shikata T. Frequent integration of hepatitis B virus DNA in non cancerous liver tissue from hepatocellular carcinoma patients. J Med Virol 1988;26:7-14.
2. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y et al. Inter-relationship of blood transfusion, non-A non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12:671-5.
3. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Schender PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20.
4. Anthony PP. Tumours and tumour-like lesions of the liver and biliary tract. In: Mac Sween RN, Anthony PP, Scheuer PJ, editors. Pathology of the liver. Edinburgh: Churchill-Livingstone, 1987:574-645.
5. Tanaka S, Hattori N. The role of HBV in hepatocellular carcinoma. In: Tobe T, Kameda H, Okudaira M, Ohto M, Endo Y, Mito M et al editors. Primary liver cancer in Japan. Tokyo: Springer Verlag, 1992:61-7.
6. Shikata T. Hepatitis C Virus infection and hepatocellular carcinoma. In: Tobe T, Kameda H, Okudaira M, Ohto M, Endo Y, Mito M et al. editors. Primary liver cancer in Japan. Tokyo: Springer Verlag, 1992:69-73.
7. The Liver Cancer Study Group of Japan. Primary Liver Cancer in Japan: clinicopathologic features and results of surgical treatment. Ann Surg 1990;211:277-87.
8. Omata M, Ashcavai M, Liew CT, Peters R. Hepatocellular carcinoma in the USA: etiologic considerations. Gastroenterology 1979;76:279-87.
9. Zur Hausen H. Intracellular surveillance of persisting viral infection. Lancet 1986;2:489-91.
10. Romeo G, Fiorucci G, Rossi GB. Interferons in cell growth and development. Trends Gen 1989;5:19-27.
11. Ludwig CU, Durie BGM, Salmon SE, Moon TE. Tumor growth stimulation in vitro by interferons. Eur J Clin Oncol 1983;19:1625-9.
12. Gutch MJ, Reich NC. Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene. Proc Natl Acad Sci USA 1991;88:7914-8.
13. Foster GR, Ackrill AM, Goldin RD, Kerr IM, Thomas HC, Stark GR. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. Proc Natl Acad Sci USA 1991;88:2888-91.
14. Kanda K, Aman P, Von Gabain A, Kallin B. The Epstein-Barr virus nuclear antigens EBNA-2 interferes with the transcriptional control of the IFN stimulated genes. J Interferon Res 1991;11(Suppl 1):S152-S154.
15. Malaguarnera M, Di Fazio I, Laurino A, Ferlito L, Romano M, Trovato BA. Serum interleukin 6 concentrations in chronic Hepatitis C patients before and after interferon alpha treatment. Int J Clin Pharmacol Therap 1997;35(9):385-8.
16. Malaguarnera M, Di Fazio I, Laurino A, Motta M, Giugno I, Trovato BA. Rôle de l'interleukine 6 dans le carcinome hépatocellulaire. Bull Cancer 1996;83:379-84.
17. Brenning G. The in vitro effect of leukocyte alpha interferon on human myeloma cells in a semisolid agar culture system. Scand J Haematol 1985;35:175-9.
18. Blade J, Lopez-Guillermo A, Tassies D, Montserrai E, Rozman C. Development of aggressive plasma cell leukaemia under interferon-alpha therapy. Br J Haematol 1991;79:523-6.
19. Tsuruo T, Iida H, Tsukagoshi S, Oku T, Kishida T. Different susceptibilities of cultured mouse cell lines to mouse interferon. Gann 1982;73:42-5.
20. Onitsuka A, Yamada N, Yasuda H, Miyata T, Kachi T. Rapid growth of hepatocellular carcinoma after or during interferon treatment for chronic hepatitis C: report of three cases. Jpn J Surg 1996;26:126-30.